2025 Q3 -tulosraportti
84 päivää sitten52 min
1,55 DKK/osake
Viimeisin osinko
0,00%Tuotto/v
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
1 594
Myynti
Määrä
579
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 26 | - | - | ||
| 356 | - | - | ||
| 670 | - | - | ||
| 31 | - | - | ||
| 111 | - | - |
Ylin
109,65VWAP
Alin
105,75VaihtoMäärä
44,8 417 647
VWAP
Ylin
109,65Alin
105,75VaihtoMäärä
44,8 417 647
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 100 000 | 100 000 | 0 | 100 000 |
| Danske Bank A/S | 5 000 | 5 000 | 0 | 5 000 |
| Anonyymi | 316 047 | 316 047 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 100 000 | 100 000 | 0 | 100 000 |
| Danske Bank A/S | 5 000 | 5 000 | 0 | 5 000 |
| Anonyymi | 316 047 | 316 047 | 0 | 0 |
Yhtiötapahtumat
Datan lähde: Quartr, FactSet| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 5.2. 7 päivää |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 6.11.2025 | |
| 2025 Q2 -tulosraportti | 21.8.2025 | |
| 2025 Q1 -tulosraportti | 1.5.2025 | |
| Vuosittainen yhtiökokous 2025 | 12.3.2025 | |
| 2024 Q4 -tulosraportti | 6.2.2025 |
Asiakkaat katsoivat myös
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
·2 t sittenCalculation Short has increased by approx 0.15% over two days in three rounds - as reported below in the thread. GN's market value is approx. 15.7 billion 0.15% corresponds to approx 40 million. If one compares with an average daily turnover of approx. 40 million, one gets, when adjusting for a little noise from other trades, that the shorters have been almost solely responsible for pushing the price down. Isn't that reasonably correct - or have I made a mistake in the calculation?
·3 t sitten · MuokattuWhy it can make sense to hold GN, even with significant short attacks, recently, and what is realistically needed for a short squeeze: 1) The turnaround is being “proven in the financial statements” (not just in PowerPoints) GN has delivered several data points that typically crush the classic short narrative (“weak cash flow + falling margin + no control”): Q3 2025: 1% organic growth, 11% EBITA margin, and DKK 410m cash flow. Q2 2025: EBITA +46% to DKK 546m (13% margin) + DKK 353m free cash flow (ex M&A), and leverage down to 4.0x from 4.9x the year before. It is these kinds of selective improvements I believe in, which make it more expensive and dangerous to be short, because the “fundamentals” are starting to support the share price. 2) Product news, market shares and pricing power Shorts love companies that “have nothing new” in a cycle. GN actually has a filled pipeline and has launched broadly: Major innovations in hearing + enterprise (e.g. ReSound Vivia and others). New hearing launches like ReSound Enzo IA (the super power segment). The D2C/OTC area is strengthened via Jabra Enhance launches. If the upcoming financial report shows that these launches lift the mix (better margin) or maintain volume, then it will be difficult to argue for “structural deterioration”. The financial report on Feb 5, 2026 is a classic catalyst The next financial report is stated for February 5, 2026. Shorts often play “catalyst roulette”: they push the price down/keep a lid on it leading up to the financial report, and hope for disappointment or caution in guidance. If GN delivers just one of these, the short side will have a problem: - Guidance up (or tighter range with better margin expectation) - Cash flow better than feared (working capital discipline) - Margin continues up (mix + cost program) Comments on market shares / order book in enterprise. _____________________ Short squeeze: What is needed (realistically)? - A squeeze normally requires 3 things simultaneously: - Upside surprise (numbers/guidance) - Volume (buyers who actually show up) - Shorts cannot/will not hold (risk limits, margin calls, or expensive to borrow the stock) With approx. 11% short, the “fuel” is there, but the match is the financial report + guidance. No match = no squeeze, just more noise. ______________________ Why the share price “is attacked” even when GN is doing well It is microstructure: - Shorts often exploit low liquidity in periods and technical levels. - “Good news” is sold if the market believes it is already priced in. If many are positioned similarly (longs and shorts), the share price becomes a battleground around catalysts. Therefore, I'm really looking forward to the financial report. :-) ______________________________ Furthermore, I would like to hear if GN continues the EBITA margin upwards? and do they deliver stable cash flow? Has GN become better at converting the product pipeline into commercial traction?- ·4 t sittenStatus 28.01.2026, 14.35 + 0.16% 10.73% The shorters seem to keep buying up. How long dare they continue with that? https://www.zirium.dk/short-watch-details?code=DK0010272632
·22 t sittenMy hope is that the shorters get a thrashing. Selling nothing in these negative times. Remember, tomorrow is another day.
·21 t sittenMy 15 mio shares is after all a lot to have to buy back in the open market!! but unfortunately, that's not how it works anymore. as Big money plays by its own rules with their countless subsidiaries and complex options/derviates. which are only traded between the various Hedge funds. therefore, we rarely see a shortsqueeze anymore!!
·21 t sittenThey have typically made agreements on buybacks so you don't see a shortsqueeze in the C25 index.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
2025 Q3 -tulosraportti
84 päivää sitten52 min
1,55 DKK/osake
Viimeisin osinko
0,00%Tuotto/v
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·2 t sittenCalculation Short has increased by approx 0.15% over two days in three rounds - as reported below in the thread. GN's market value is approx. 15.7 billion 0.15% corresponds to approx 40 million. If one compares with an average daily turnover of approx. 40 million, one gets, when adjusting for a little noise from other trades, that the shorters have been almost solely responsible for pushing the price down. Isn't that reasonably correct - or have I made a mistake in the calculation?
- ·3 t sitten · MuokattuWhy it can make sense to hold GN, even with significant short attacks, recently, and what is realistically needed for a short squeeze: 1) The turnaround is being “proven in the financial statements” (not just in PowerPoints) GN has delivered several data points that typically crush the classic short narrative (“weak cash flow + falling margin + no control”): Q3 2025: 1% organic growth, 11% EBITA margin, and DKK 410m cash flow. Q2 2025: EBITA +46% to DKK 546m (13% margin) + DKK 353m free cash flow (ex M&A), and leverage down to 4.0x from 4.9x the year before. It is these kinds of selective improvements I believe in, which make it more expensive and dangerous to be short, because the “fundamentals” are starting to support the share price. 2) Product news, market shares and pricing power Shorts love companies that “have nothing new” in a cycle. GN actually has a filled pipeline and has launched broadly: Major innovations in hearing + enterprise (e.g. ReSound Vivia and others). New hearing launches like ReSound Enzo IA (the super power segment). The D2C/OTC area is strengthened via Jabra Enhance launches. If the upcoming financial report shows that these launches lift the mix (better margin) or maintain volume, then it will be difficult to argue for “structural deterioration”. The financial report on Feb 5, 2026 is a classic catalyst The next financial report is stated for February 5, 2026. Shorts often play “catalyst roulette”: they push the price down/keep a lid on it leading up to the financial report, and hope for disappointment or caution in guidance. If GN delivers just one of these, the short side will have a problem: - Guidance up (or tighter range with better margin expectation) - Cash flow better than feared (working capital discipline) - Margin continues up (mix + cost program) Comments on market shares / order book in enterprise. _____________________ Short squeeze: What is needed (realistically)? - A squeeze normally requires 3 things simultaneously: - Upside surprise (numbers/guidance) - Volume (buyers who actually show up) - Shorts cannot/will not hold (risk limits, margin calls, or expensive to borrow the stock) With approx. 11% short, the “fuel” is there, but the match is the financial report + guidance. No match = no squeeze, just more noise. ______________________ Why the share price “is attacked” even when GN is doing well It is microstructure: - Shorts often exploit low liquidity in periods and technical levels. - “Good news” is sold if the market believes it is already priced in. If many are positioned similarly (longs and shorts), the share price becomes a battleground around catalysts. Therefore, I'm really looking forward to the financial report. :-) ______________________________ Furthermore, I would like to hear if GN continues the EBITA margin upwards? and do they deliver stable cash flow? Has GN become better at converting the product pipeline into commercial traction?
- ·4 t sittenStatus 28.01.2026, 14.35 + 0.16% 10.73% The shorters seem to keep buying up. How long dare they continue with that? https://www.zirium.dk/short-watch-details?code=DK0010272632
- ·22 t sittenMy hope is that the shorters get a thrashing. Selling nothing in these negative times. Remember, tomorrow is another day.·21 t sittenMy 15 mio shares is after all a lot to have to buy back in the open market!! but unfortunately, that's not how it works anymore. as Big money plays by its own rules with their countless subsidiaries and complex options/derviates. which are only traded between the various Hedge funds. therefore, we rarely see a shortsqueeze anymore!!·21 t sittenThey have typically made agreements on buybacks so you don't see a shortsqueeze in the C25 index.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
1 594
Myynti
Määrä
579
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 26 | - | - | ||
| 356 | - | - | ||
| 670 | - | - | ||
| 31 | - | - | ||
| 111 | - | - |
Ylin
109,65VWAP
Alin
105,75VaihtoMäärä
44,8 417 647
VWAP
Ylin
109,65Alin
105,75VaihtoMäärä
44,8 417 647
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 100 000 | 100 000 | 0 | 100 000 |
| Danske Bank A/S | 5 000 | 5 000 | 0 | 5 000 |
| Anonyymi | 316 047 | 316 047 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 100 000 | 100 000 | 0 | 100 000 |
| Danske Bank A/S | 5 000 | 5 000 | 0 | 5 000 |
| Anonyymi | 316 047 | 316 047 | 0 | 0 |
Asiakkaat katsoivat myös
Yhtiötapahtumat
Datan lähde: Quartr, FactSet| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 5.2. 7 päivää |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 6.11.2025 | |
| 2025 Q2 -tulosraportti | 21.8.2025 | |
| 2025 Q1 -tulosraportti | 1.5.2025 | |
| Vuosittainen yhtiökokous 2025 | 12.3.2025 | |
| 2024 Q4 -tulosraportti | 6.2.2025 |
2025 Q3 -tulosraportti
84 päivää sitten52 min
Uutiset
Tämän sivun uutiset ja/tai sijoitussuositukset tai otteet niistä sekä niihin liittyvät linkit ovat mainitun tahon tuottamia ja toimittamia. Nordnet ei ole osallistunut materiaalin laatimiseen, eikä ole tarkistanut sen sisältöä tai tehnyt sisältöön muutoksia. Lue lisää sijoitussuosituksista.
Yhtiötapahtumat
Datan lähde: Quartr, FactSet| Seuraava tapahtuma | |
|---|---|
| 2025 Q4 -tulosraportti | 5.2. 7 päivää |
| Menneet tapahtumat | ||
|---|---|---|
| 2025 Q3 -tulosraportti | 6.11.2025 | |
| 2025 Q2 -tulosraportti | 21.8.2025 | |
| 2025 Q1 -tulosraportti | 1.5.2025 | |
| Vuosittainen yhtiökokous 2025 | 12.3.2025 | |
| 2024 Q4 -tulosraportti | 6.2.2025 |
1,55 DKK/osake
Viimeisin osinko
0,00%Tuotto/v
Shareville
Liity keskusteluun SharevillessäShareville on aktiivisten yksityissijoittajien yhteisö, jossa voit seurata muiden asiakkaiden kaupankäyntiä ja omistuksia.
Kirjaudu
- ·2 t sittenCalculation Short has increased by approx 0.15% over two days in three rounds - as reported below in the thread. GN's market value is approx. 15.7 billion 0.15% corresponds to approx 40 million. If one compares with an average daily turnover of approx. 40 million, one gets, when adjusting for a little noise from other trades, that the shorters have been almost solely responsible for pushing the price down. Isn't that reasonably correct - or have I made a mistake in the calculation?
- ·3 t sitten · MuokattuWhy it can make sense to hold GN, even with significant short attacks, recently, and what is realistically needed for a short squeeze: 1) The turnaround is being “proven in the financial statements” (not just in PowerPoints) GN has delivered several data points that typically crush the classic short narrative (“weak cash flow + falling margin + no control”): Q3 2025: 1% organic growth, 11% EBITA margin, and DKK 410m cash flow. Q2 2025: EBITA +46% to DKK 546m (13% margin) + DKK 353m free cash flow (ex M&A), and leverage down to 4.0x from 4.9x the year before. It is these kinds of selective improvements I believe in, which make it more expensive and dangerous to be short, because the “fundamentals” are starting to support the share price. 2) Product news, market shares and pricing power Shorts love companies that “have nothing new” in a cycle. GN actually has a filled pipeline and has launched broadly: Major innovations in hearing + enterprise (e.g. ReSound Vivia and others). New hearing launches like ReSound Enzo IA (the super power segment). The D2C/OTC area is strengthened via Jabra Enhance launches. If the upcoming financial report shows that these launches lift the mix (better margin) or maintain volume, then it will be difficult to argue for “structural deterioration”. The financial report on Feb 5, 2026 is a classic catalyst The next financial report is stated for February 5, 2026. Shorts often play “catalyst roulette”: they push the price down/keep a lid on it leading up to the financial report, and hope for disappointment or caution in guidance. If GN delivers just one of these, the short side will have a problem: - Guidance up (or tighter range with better margin expectation) - Cash flow better than feared (working capital discipline) - Margin continues up (mix + cost program) Comments on market shares / order book in enterprise. _____________________ Short squeeze: What is needed (realistically)? - A squeeze normally requires 3 things simultaneously: - Upside surprise (numbers/guidance) - Volume (buyers who actually show up) - Shorts cannot/will not hold (risk limits, margin calls, or expensive to borrow the stock) With approx. 11% short, the “fuel” is there, but the match is the financial report + guidance. No match = no squeeze, just more noise. ______________________ Why the share price “is attacked” even when GN is doing well It is microstructure: - Shorts often exploit low liquidity in periods and technical levels. - “Good news” is sold if the market believes it is already priced in. If many are positioned similarly (longs and shorts), the share price becomes a battleground around catalysts. Therefore, I'm really looking forward to the financial report. :-) ______________________________ Furthermore, I would like to hear if GN continues the EBITA margin upwards? and do they deliver stable cash flow? Has GN become better at converting the product pipeline into commercial traction?
- ·4 t sittenStatus 28.01.2026, 14.35 + 0.16% 10.73% The shorters seem to keep buying up. How long dare they continue with that? https://www.zirium.dk/short-watch-details?code=DK0010272632
- ·22 t sittenMy hope is that the shorters get a thrashing. Selling nothing in these negative times. Remember, tomorrow is another day.·21 t sittenMy 15 mio shares is after all a lot to have to buy back in the open market!! but unfortunately, that's not how it works anymore. as Big money plays by its own rules with their countless subsidiaries and complex options/derviates. which are only traded between the various Hedge funds. therefore, we rarely see a shortsqueeze anymore!!·21 t sittenThey have typically made agreements on buybacks so you don't see a shortsqueeze in the C25 index.
Yllä olevat kommentit ovat peräisin Nordnetin sosiaalisen verkoston Sharevillen käyttäjiltä, eikä niitä ole muokattu eikä Nordnet ole tarkastanut niitä etukäteen. Ne eivät tarkoita, että Nordnet tarjoaisi sijoitusneuvoja tai sijoitussuosituksia. Nordnet ei ota vastuuta kommenteista.
Tarjoustasot
Nasdaq Copenhagen
Määrä
Osto
1 594
Myynti
Määrä
579
Viimeisimmät kaupat
| Aika | Hinta | Määrä | Ostaja | Myyjä |
|---|---|---|---|---|
| 26 | - | - | ||
| 356 | - | - | ||
| 670 | - | - | ||
| 31 | - | - | ||
| 111 | - | - |
Ylin
109,65VWAP
Alin
105,75VaihtoMäärä
44,8 417 647
VWAP
Ylin
109,65Alin
105,75VaihtoMäärä
44,8 417 647
Välittäjätilasto
Ostaneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 100 000 | 100 000 | 0 | 100 000 |
| Danske Bank A/S | 5 000 | 5 000 | 0 | 5 000 |
| Anonyymi | 316 047 | 316 047 | 0 | 0 |
Myyneet eniten
| Välittäjä | Ostettu | Myyty | Netto | Sisäinen |
|---|---|---|---|---|
| Nordea Bank Abp | 100 000 | 100 000 | 0 | 100 000 |
| Danske Bank A/S | 5 000 | 5 000 | 0 | 5 000 |
| Anonyymi | 316 047 | 316 047 | 0 | 0 |